EA-230, a powerful and precise inhibitor, finds its application in the biomedical realm for efficacious intervention against a myriad of cancer types, encompassing lung, breast, and colorectal cancer. Employing a mechanism targeting distinct protein kinases implicated in the proliferation of tumors and the formation of blood vessels, this compound exhibits remarkable potential.
CAT# | R2054 |
CAS | 503844-09-5 |
Chemical Name | (2S)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-aminopropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-methylbutanoic acid |
M.F/Formula | C15H27N5O6 |
M.W/Mr. | 373.40 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Elcatonin acetate, a physicochemically and biologically stable synthetic derivative of calcitonin transformed fr ...
Phosphoramidon is a kind of thermolysin inhibitor isolated from a culture filtrate of streptomyces. It has prove ...
Developed by the German company Hoechst Marion Roussel and derived from genetic modification of hirudin, lepirud ...
Fertirelin acetate, classified into peptide hormone, is a gonadotropin-releasing hormone (GnRH) antagonist or ...
The cyclopentapeptide FC 131 (cyclo(-L-Arg1-L-Arg2-L-2-Nal3-Gly4-D-Tyr5-), 2-Nal=3-(2-naphthyl) alanine)) is an ...